{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:17:06Z","timestamp":1788365826824,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017592","name":"Key Science and Technology Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2018ZDXM-SF-039"],"award-info":[{"award-number":["2018ZDXM-SF-039"]}],"id":[{"id":"10.13039\/501100017592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017592","name":"Key Science and Technology Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2022JQ-812"],"award-info":[{"award-number":["2022JQ-812"]}],"id":[{"id":"10.13039\/501100017592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017592","name":"Key Science and Technology Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2020ZDLSF02-01"],"award-info":[{"award-number":["2020ZDLSF02-01"]}],"id":[{"id":"10.13039\/501100017592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017592","name":"Key Science and Technology Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2025JC-YBMS-899"],"award-info":[{"award-number":["2025JC-YBMS-899"]}],"id":[{"id":"10.13039\/501100017592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcyt.2026.102781","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:17:39Z","timestamp":1773458259000},"page":"102781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nutritional and immunologic scoring systems to predict complications and outcomes after anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy in relapsed\/refractory multiple myeloma"],"prefix":"10.1016","volume":"28","author":[{"given":"Xuezhu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanggang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liufang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcyt.2026.102781_bib0001","first-page":"669","article-title":"FDA approves first CAR T therapy","volume":"16","author":"Mullard","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102781_bib0002","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102781_bib0004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102781_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.2023020578","article-title":"Immune effector cell-associated hematotoxicity: EHA\/EBMT consensus grading and best practice recommendations","volume":"142","author":"Rejeski","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102781_bib0006","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00134-024-07576-4","article-title":"Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities","volume":"50","author":"Schroeder","year":"2024","journal-title":"Intensive Care Medicine"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102781_bib0007","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17474086.2022.2063833","article-title":"Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians","volume":"15","author":"Kampouri","year":"2022","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102781_bib0008","doi-asserted-by":"crossref","first-page":"ofaa121","DOI":"10.1093\/ofid\/ofaa121","article-title":"Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults","volume":"7","author":"Vora","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102781_bib0009","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbmt.2019.11.027","article-title":"Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies","volume":"26","author":"Wang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2026.102781_bib0010","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1007\/s00520-022-07358-y","article-title":"Nutrition support use and clinical outcomes in patients with multiple myeloma undergoing autologous stem cell transplant","volume":"30","author":"Kuypers","year":"2022","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102781_bib0011","first-page":"1441","article-title":"The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy","volume":"28","author":"Yilmaz","year":"2020","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0012","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/bmt.2014.228","article-title":"Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality","volume":"50","author":"Fuji","year":"2015","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102781_bib0013","first-page":"152","article-title":"Optimization of nutrition during allogeneic hematologic stem cell transplantation","volume":"21","author":"Baumgartner","year":"2018","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jcyt.2026.102781_bib0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/CBM-210073","article-title":"Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple myeloma","volume":"32","author":"Zhou","year":"2021","journal-title":"Cancer Biomarkers"},{"issue":"19","key":"10.1016\/j.jcyt.2026.102781_bib0015","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.3390\/nu15194210","article-title":"Nutritional Status Indices and Monoclonal Gammopathy of Undetermined Significance Risk in the Elderly Population: Findings from the National Health and Nutrition Examination Survey","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/CBM-210073","article-title":"Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple myeloma","volume":"32","author":"Zhou","year":"2021","journal-title":"Cancer Biomark"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102781_bib0017","first-page":"1001","article-title":"[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0018","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.18054","article-title":"Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma","volume":"197","author":"Roy","year":"2022","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102781_bib0019","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-22-0487","article-title":"Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy","volume":"11","author":"Rejeski","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.jcyt.2026.102781_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clnesp.2024.05.020","article-title":"Malnutrition and cachexia are associated with poor CAR T-cell therapy outcomes including survival","volume":"62","author":"Cucchiaro","year":"2024","journal-title":"Clinical Nutrition ESPEN"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0021","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1186\/s12885-023-11590-y","article-title":"Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma","volume":"23","author":"Go","year":"2023","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102781_bib0022","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1016\/j.clnu.2021.08.023","article-title":"Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis","volume":"40","author":"Surov","year":"2021","journal-title":"Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13045-018-0681-6","article-title":"A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma","volume":"11","author":"Zhao","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102781_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.46989\/001c.115932","article-title":"Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy","volume":"6","author":"Ahmed","year":"2024","journal-title":"Clin Hematol Int"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbmt.2019.08.003","article-title":"Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells","volume":"26","author":"Cordeiro","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102781_bib0026","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102781_bib0027","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2352-3026(24)00077-2","article-title":"Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management","volume":"11","author":"Rejeski","year":"2024","journal-title":"The Lancet Haematology"},{"issue":"14","key":"10.1016\/j.jcyt.2026.102781_bib0028","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/CM9.0000000000002288","article-title":"Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy","volume":"135","author":"Mei","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102781_bib0029","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hon.3155","article-title":"A comprehensive analysis of coagulopathy during anti-B cell maturation antigen chimeric antigen receptor-T therapy in multiple myeloma, a retrospective study based on LEGEND-2","volume":"41","author":"Liu","year":"2023","journal-title":"Hematological Oncology"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0030","first-page":"38","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"Ignacio de Ul\u00edbarri","year":"2005","journal-title":"Nutr Hosp"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24132","article-title":"Malnutrition on admission increases the in-hospital mortality and length of stay in elder adults with acute ischemic stroke","volume":"36","author":"Hao","year":"2022","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11748-019-01150-2","article-title":"The prognostic nutritional index in resected high-grade pulmonary neuroendocrine carcinoma","volume":"68","author":"Okui","year":"2020","journal-title":"General Thoracic and Cardiovascular Surgery"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102781_bib0033","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00595-019-01862-1","article-title":"Preoperative change of modified Glasgow prognostic score after stenting predicts the long-term outcomes of obstructive colorectal cancer","volume":"50","author":"Sato","year":"2020","journal-title":"Surgery Today"},{"issue":"21","key":"10.1016\/j.jcyt.2026.102781_bib0034","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.jcyt.2026.102781_bib0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/86.11.829","article-title":"Dangers of using \"optimal\" cutpoints in the evaluation of prognostic factors","volume":"86","author":"Altman","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0036","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00384-021-04043-0","article-title":"Comparison of nutritional and immunological scoring systems predicting prognosis in T1-2N0 colorectal cancer","volume":"37","author":"Pian","year":"2022","journal-title":"International Journal of Colorectal Disease"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102781_bib0037","first-page":"3321","article-title":"Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study","volume":"30","author":"Ding","year":"2022","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102781_bib0038","doi-asserted-by":"crossref","first-page":"283.e1","DOI":"10.1016\/j.jtct.2023.12.010","article-title":"Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy","volume":"30","author":"Akhtar","year":"2024","journal-title":"Transplantation and Cellular Therapy"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0039","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1080\/07853890.2022.2136748","article-title":"Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors","volume":"54","author":"Xia","year":"2022","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/bloodadvances.2024014555","article-title":"Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes","volume":"9","author":"Valtis","year":"2024","journal-title":"Blood Advances"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102781_bib0041","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.nut.2014.12.005","article-title":"Why the oncologist should consider the nutritional status of the elderly cancer patient","volume":"31","author":"Bozzetti","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.jcyt.2026.102781_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1039591","article-title":"Effects of blood flow restriction training on anthropometric and blood lipids in overweight\/obese adults: Meta-analysis","volume":"13","author":"Sun","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcyt.2026.102781_bib0043","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2019.00033","article-title":"The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management","volume":"10","author":"Patel","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102781_bib0044","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaci.2024.10.021","article-title":"Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality","volume":"155","author":"Sutherland","year":"2025","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.jcyt.2026.102781_bib0045","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1007\/s00210-024-03740-1","article-title":"Coagulation in familial hypercholesterolemic patients: effect of current hypolipidemic treatment and anticoagulants","volume":"398","author":"Fadraersada","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102781_bib0046","first-page":"e2533","article-title":"Evaluation of coagulopathy frequency and risk factors in trauma patients in intensive care unit","volume":"25","author":"Do\u011fanc\u0131","year":"2023","journal-title":"Iranian Red Crescent Medical Journal (IRCMJ)"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102781_bib0047","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/hep4.1622","article-title":"Coagulopathy in Malnourished Mice Is Sexually Dimorphic and Regulated by Nutrient-Sensing Nuclear Receptors","volume":"4","author":"Preidis","year":"2020","journal-title":"Hepatology Communications"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102781_bib0048","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13287-016-0377-1","article-title":"C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1\u03b1 via CD64\/PI3k\/Akt and MAPK\/ERK signaling pathways","volume":"7","author":"Chen","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"1-2","key":"10.1016\/j.jcyt.2026.102781_bib0049","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/01635581.2001.9680613","article-title":"Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer","volume":"41","author":"McMillan","year":"2001","journal-title":"Nutr Cancer"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102781_bib0050","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.gassur.2004.09.033","article-title":"Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia","volume":"8","author":"Lien","year":"2004","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102781_bib0051","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926007425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926007425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:24:22Z","timestamp":1788362662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926007425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1465324926007425"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102781","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional and immunologic scoring systems to predict complications and outcomes after anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy in relapsed\/refractory multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102781"}}